These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8225635)

  • 1. Biliary tract infections treated with ciprofloxacin.
    Karachalios GN; Zografos G; Patrikakos V; Nassopoulou D; Kehagioglou K
    Infection; 1993; 21(4):262-4. PubMed ID: 8225635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biliary tract infections: a guide to drug treatment.
    Westphal JF; Brogard JM
    Drugs; 1999 Jan; 57(1):81-91. PubMed ID: 9951953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical studies of BRL 28500 (clavulanic acid/ticarcillin) in the treatment of intraperitoneal infections and biliary tract infections].
    Sakai K; Ueda T; Uchino J; Hayasaka A; Shiramatsu K; Nagamachi Y; Shoda Y; Okui K; Hayata Y; Watanabe H
    Jpn J Antibiot; 1987 Apr; 40(4):759-811. PubMed ID: 3302345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous ciprofloxacin as treatment for patients with acute suppurative cholangitis: a randomized, controlled clinical trial.
    Sung JJ; Lyon DJ; Suen R; Chung SC; Co AL; Cheng AF; Leung JW; Li AK
    J Antimicrob Chemother; 1995 Jun; 35(6):855-64. PubMed ID: 7559196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of the clinical effectiveness of aztreonam in gram-negative infections of the biliary tract].
    Pedretti G; Magnani G
    G Ital Chemioter; 1988; 35(1-3):45-8. PubMed ID: 3256512
    [No Abstract]   [Full Text] [Related]  

  • 6. Prospective, randomized comparison of sequential intravenous followed by oral ciprofloxacin with intravenous ceftazidime in the treatment of serious infections.
    Peacock JE; Pegram PS; Weber SF; Leone PA
    Am J Med; 1989 Nov; 87(5A):185S-190S. PubMed ID: 2686421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical evaluation of ciprofloxacin on biliary tract infection following oral administration].
    Nakamura T; Hashimoto I; Sawada Y; Mikami J; Bekki E
    Jpn J Antibiot; 1986 Oct; 39(10):2675-84. PubMed ID: 3806954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of biliary tract-associated bloodstream infections and adequacy of empiric therapy: an Australian population-based study.
    Gassiep I; Edwards F; Laupland KB
    Eur J Clin Microbiol Infect Dis; 2024 Sep; 43(9):1753-1760. PubMed ID: 38985222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous/oral ciprofloxacin versus ceftazidime in the treatment of serious infections.
    Fass RJ; Plouffe JF; Russell JA
    Am J Med; 1989 Nov; 87(5A):164S-168S. PubMed ID: 2589361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of acute biliary tract infections with ofloxacin: a randomized, controlled clinical trial.
    Karachalios GN; Nasiopoulou DD; Bourlinou PK; Reppa A
    Int J Clin Pharmacol Ther; 1996 Dec; 34(12):555-7. PubMed ID: 8996852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical impact of inappropriate initial antimicrobial therapy on outcome in bacteremic biliary tract infections.
    Kang CI; Sung YK; Lee KH; Lee KT; Lee JK
    Scand J Infect Dis; 2013 Mar; 45(3):227-34. PubMed ID: 23113605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Doxycycline in inflammatory diseases of the biliary tract].
    Benda L
    Wien Med Wochenschr; 1969 Aug; 119(33):567-72. PubMed ID: 5801226
    [No Abstract]   [Full Text] [Related]  

  • 13. Listeria monocytogenes-associated biliary tract infections: a study of 12 consecutive cases and review.
    Charlier C; Fevre C; Travier L; Cazenave B; Bracq-Dieye H; Podevin J; Assomany D; Guilbert L; Bossard C; Carpentier F; Cales V; Leclercq A; Lecuit M
    Medicine (Baltimore); 2014 Oct; 93(18):e105. PubMed ID: 25319439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic prophylaxis for ERCP: a randomized clinical trial comparing ciprofloxacin and cefuroxime in 200 patients at high risk of cholangitis.
    Mehal WZ; Culshaw KD; Tillotson GS; Chapman RW
    Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):841-5. PubMed ID: 8574715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous ciprofloxacin and ceftazidime in serious infections. A prospective, controlled clinical trial with third-party blinding.
    Sifuentes-Osornio J; Macías A; Amieva RI; Ramos A; Ruiz-Palacios GM
    Am J Med; 1989 Nov; 87(5A):202S-205S. PubMed ID: 2686425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rifamide in acute cholecystitis and biliary surgery.
    Bevan PG; Williams JD
    Br Med J; 1971 Jul; 3(5769):284-7. PubMed ID: 5557539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of ciprofloxacin with netilmicin for the treatment of acute pyelonephritis.
    Bailey RR; Lynn KL; Robson RA; Peddie BA; Smith A
    N Z Med J; 1992 Mar; 105(930):102-3. PubMed ID: 1553112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chemotherapy of biliary tract infections (XXXVII). Excretion into bile and gallbladder tissue levels of levofloxacin and its clinical effect in biliary tract infections].
    Tanimura H; Ohnishi H; Okamura T; Uenishi M; Ichimiya G; Kobayashi Y; Aoki Y; Oka S; Yamamoto S; Shimada K
    Jpn J Antibiot; 1992 May; 45(5):557-68. PubMed ID: 1512942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of serious infections with intravenous ciprofloxacin.
    Scully BE; Neu HC
    Am J Med; 1987 Apr; 82(4A):369-75. PubMed ID: 3555062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies on cefoperazone concentration in human biliary tract and clinical effect for acute cholecystitis and cholangitis (author's transl)].
    Hirasawa S; Abe H; Bekki E; Hashimoto I; Sawada Y; Nakamura T; Mikami J; Watanabe Y
    Jpn J Antibiot; 1980 Dec; 33(12):1294-300. PubMed ID: 6454012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.